AOD-9604 dosage for fat loss in Canada typically ranges from 250 mcg to 500 mcg per day, injected subcutaneously, with most users following a 12 to 20 week cycle. This peptide is a modified fragment of human growth hormone (hGH) designed to target fat metabolism without the blood sugar side effects of full hGH. If you are researching AOD-9604 fat loss in Canada, this guide covers the exact protocol, cycle length, and practical sourcing considerations.
What Is AOD-9604 and How Does It Work for Fat Loss?
AOD-9604 is a synthetic peptide fragment consisting of amino acids 177-191 of the human growth hormone molecule. It was originally developed by Professor Frank Ng at Monash University in Australia. The peptide is specifically engineered to retain the lipolytic (fat burning) region of hGH while removing the growth-promoting and insulin-resistance effects. This makes AOD-9604 a targeted agent for fat loss research.
The primary mechanism of AOD-9604 fat loss involves stimulating lipolysis, the breakdown of stored triglycerides into free fatty acids. It also inhibits lipogenesis, which is the creation of new fat from non-fat sources like carbohydrates. Unlike full hGH, AOD-9604 does not significantly raise IGF-1 levels or affect blood glucose. This is a key advantage for researchers studying fat reduction without metabolic disruption.
In animal studies, AOD-9604 showed a reduction in body fat in obese mice without changes in food intake or insulin sensitivity. Human trials have been more mixed. A 12-week randomized controlled trial in obese adults found no significant difference in weight loss compared to placebo when combined with diet and exercise. However, some users report noticeable fat loss, especially in stubborn areas like the abdomen. The peptide remains popular in research communities for its safety profile and targeted action.
AOD-9604 Dosage for Fat Loss: The Standard Protocol
The most common AOD-9604 dosage for fat loss is 250 mcg to 500 mcg per day. This is typically split into one or two subcutaneous injections. Because AOD-9604 has a short half-life of about 30 minutes, some researchers prefer twice-daily dosing to maintain more consistent blood levels. A typical protocol might be 250 mcg in the morning and 250 mcg in the evening.
For beginners, starting at 250 mcg once daily is reasonable to assess tolerance. After one to two weeks, the dose can be increased to 500 mcg per day if no adverse effects occur. Some advanced protocols go up to 1 mg per day, but this is less common and not necessarily more effective. The peptide is generally well tolerated, with few reported side effects at standard doses.
It is important to note that AOD-9604 is not a magic bullet. It works best when combined with a caloric deficit and regular physical activity. The peptide may enhance fat oxidation during exercise and at rest, but it cannot override a poor diet. Researchers should track body composition changes over the full cycle, not just scale weight.
How to Reconstitute and Inject AOD-9604
AOD-9604 is supplied as a lyophilized powder in vials, commonly 2 mg or 5 mg. To reconstitute, add bacteriostatic water or sterile water for injection. For a 2 mg vial, adding 2 mL of water yields a concentration of 1000 mcg per mL. Then a 250 mcg dose would be 0.25 mL on an insulin syringe.
Injection sites should be rotated among the abdomen, thighs, or upper arms. Subcutaneous injection means injecting into the fatty tissue just under the skin, not into muscle. Use a 30 or 31 gauge insulin syringe for comfort. Always follow sterile procedures to avoid contamination.
Store reconstituted AOD-9604 in the refrigerator at 2-8 degrees Celsius. It should remain stable for up to 30 days when refrigerated. Unreconstituted vials can be stored in the freezer for longer-term storage. Avoid repeated freeze-thaw cycles.
AOD-9604 Cycle Length: How Long Should You Run It?
The typical AOD-9604 cycle length for fat loss is 12 to 20 weeks. This extended duration allows the peptide to exert its metabolic effects gradually. Fat loss is a slow process, and AOD-9604 is not a rapid fat burner like clenbuterol or DNP. Most users report noticeable changes after 8 to 12 weeks of consistent use.
Some researchers run shorter cycles of 8 weeks, but this may be insufficient to see significant results. Others extend cycles to 6 months, though long-term safety data in humans is limited. A practical approach is to start with a 12-week cycle, assess progress, and then decide whether to continue for another 8 weeks.
Unlike growth hormone secretagogues like Ipamorelin or CJC-1295, AOD-9604 does not require cycling to prevent receptor desensitization. It acts directly on fat cells, not through the pituitary. However, taking breaks between cycles is still recommended to allow the body to reset and to evaluate the peptide's true effect.
AOD-9604 Fat Loss Results: What to Expect
Real-world results with AOD-9604 vary widely. Some users report losing 2-4 kg of fat over a 12-week cycle, especially when combined with a structured diet and training program. Others see minimal changes. The peptide appears to work best in individuals who are already relatively lean and struggling with stubborn fat deposits.
In clinical trials, AOD-9604 did not outperform placebo for overall weight loss in obese subjects. However, a subgroup analysis suggested it may reduce abdominal fat specifically. This has led to its reputation as a spot-reduction agent, though spot reduction is scientifically controversial. The peptide may enhance lipolysis in adipose tissue more uniformly, but user anecdotes often highlight belly fat loss.
It is crucial to manage expectations. AOD-9604 is a research peptide, not an approved drug for human use. Its fat loss effects are modest compared to GLP-1 agonists like semaglutide or tirzepatide. For significant weight loss, those medications are far more effective. AOD-9604 may be better suited for body recomposition or maintaining leanness during a cutting phase.
AOD-9604 Side Effects and Safety Profile
AOD-9604 is generally well tolerated with few reported side effects. In clinical trials, the most common adverse events were mild injection site reactions, such as redness or itching. Some users report transient headaches or nausea, especially at higher doses. These effects usually subside within a few days.
Because AOD-9604 does not raise IGF-1 or affect blood glucose, it avoids the classic hGH side effects like joint pain, insulin resistance, or carpal tunnel syndrome. This makes it an attractive option for researchers concerned about metabolic side effects. However, long-term safety data beyond 6 months is lacking.
As with any injectable peptide, there is a risk of contamination or improper dosing if sourced from unreliable vendors. Always purchase from reputable suppliers that provide third-party testing. In Canada, research peptides are not approved for human consumption, so they are sold for laboratory research purposes only.
Where to Buy AOD-9604 in Canada
Finding a reliable source for AOD-9604 in Canada can be challenging. Many online vendors ship to Canada, but quality varies. Look for suppliers that offer certificates of analysis (COA) from independent labs. This confirms the peptide's purity and identity. Avoid vendors that do not provide testing or have poor customer reviews.
Price for AOD-9604 in Canada typically ranges from $30 to $60 CAD for a 2 mg vial, and $60 to $120 CAD for a 5 mg vial. Bulk discounts are often available. Be wary of prices that seem too low, as they may indicate counterfeit or underdosed product. Some Canadian research chemical companies offer domestic shipping, which avoids customs delays.
If you are researching other peptides for fat loss or recovery, you may find our guide on Semaglutide dosage for weight loss in Quebec useful. For injury recovery protocols, see our article on BPC-157 5mg dosage for injury recovery in Canada. And for anti-aging research, check out GHK-Cu dosage for anti-aging in Canada.
AOD-9604 vs Other Fat Loss Peptides
AOD-9604 is often compared to other peptides used for fat loss, such as HGH Fragment 176-191, Tesamorelin, and Ipamorelin. HGH Fragment 176-191 is essentially the same peptide as AOD-9604 but with a slightly different amino acid sequence. Tesamorelin is a growth hormone-releasing hormone analog that increases natural hGH production, which can indirectly promote fat loss. Ipamorelin is a growth hormone secretagogue that also boosts hGH levels.
Compared to these, AOD-9604 has a more direct mechanism on fat cells without affecting growth hormone levels. This may reduce the risk of side effects like water retention or joint pain. However, its fat loss effects may be less pronounced than Tesamorelin, which is FDA-approved for reducing visceral fat in HIV patients with lipodystrophy.
For researchers interested in GLP-1 agonists, semaglutide and tirzepatide are far more effective for weight loss but carry different side effect profiles. AOD-9604 is not a GLP-1 agonist and does not suppress appetite. It is purely a lipolytic agent. This makes it a niche option for those who want to target fat metabolism without hormonal disruption.
Frequently Asked Questions About AOD-9604 Dosage
Can I take AOD-9604 orally?
No, AOD-9604 is a peptide and would be destroyed in the digestive tract. It must be injected subcutaneously to be effective. Some oral formulations have been tested in clinical trials, but they showed poor bioavailability and are not commonly available.
Is AOD-9604 legal in Canada?
AOD-9604 is not approved by Health Canada for human use. It is